PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 29, 2026Cureus0 citationsOpen Access

Pulmonary Mucormycosis Presenting as Rapidly Progressive Cavitary Pneumonia and Lung Abscess in a Patient With Type 2 Diabetes Mellitus and a Solitary Functioning Kidney: A Report of a Rare Case

View Full Paper
RLRumanas LafeerPMPakkiyaretnam Mayurathan

Key Points

  • This report aims to highlight the clinical presentation and treatment challenges of pulmonary mucormycosis in a patient with type 2 diabetes mellitus.
  • Reported case of a 33-year-old woman with type 2 diabetes mellitus and a solitary functioning kidney
  • Management included treatment with intravenous liposomal amphotericin B for six weeks
  • Bronchoscopy performed and histopathology evaluated for diagnosis
  • Histopathology revealed broad aseptate fungal hyphae with right-angle branching
  • Fungal culture confirmed Rhizopus species
  • Patient experienced complications including hypomagnesemia and ongoing monitoring needs

Abstract

Pulmonary mucormycosis is an invasive fungal infection that can present with rapidly progressive pulmonary disease and may mimic bacterial pneumonia or lung abscess. This diagnostic overlap can lead to delayed recognition and treatment. We report the case of a 33-year-old woman with type 2 diabetes mellitus and a solitary functioning kidney, who presented with fever, productive cough, pleuritic chest pain, and progressive dyspnea. Serial chest radiographs demonstrated rapid progression of lung lesions from right-sided consolidation to cavitary necrosis with air-fluid level formation, consistent with lung abscess. Despite broad-spectrum antibiotic therapy, clinical and inflammatory markers worsened, prompting bronchoscopy evaluation. Histopathology revealed broad aseptate fungal hyphae with right-angle branching. Fungal culture confirmed Rhizopus species, compatible with the diagnosis of pulmonary mucormycosis. The patient was treated with intravenous liposomal amphotericin B for six weeks. The therapy was complicated by amphotericin-induced hypokalemia, hypomagnesemia, and transient liver enzyme derangement, necessitating close monitoring given her solitary functioning kidney. She demonstrated gradual clinical and biochemical improvement with appropriate antifungal therapy. This case highlights the importance of early suspicion of mucormycosis in diabetic patients with non-resolving pneumonia and underscores the challenges of managing antifungal therapy in patients with limited renal reserve.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lafeer et al. (2026) studied this question.

synapsesocial.com/papers/69f154c0879cb923c49450bdhttps://doi.org/10.7759/cureus.107813
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1D107-05 The Slow-Burning Cavity: Diagnostic Challenges of Pulmonary Mucormycosis in an Uncontrolled Diabetic2026
  2. 2Severe angioinvasive pulmonary mucormycosis in an immunocompetent patient with poorly controlled diabetes: a case report2026
  3. 3Pulmonary Mucormycosis Presenting as Non-resolving Pneumonia in an Elderly Patient With Uncontrolled Diabetes Mellitus: A Case Report2026
  4. 4B72-37 When Sugar Turns Sour: Pulmonary Mucormycosis in Uncontrolled Diabetes2026
  5. 5Pulmonary Mucormycosis in Diabetic Patients: A Case Series From a Tertiary Respiratory Center in Sri Lanka2025 · 1 citations